Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Sanara MedTech (SMTI) Shares Outstanding (2016 - 2025)

Sanara MedTech's Shares Outstanding history spans 15 years, with the latest figure at $8.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 2.21% year-over-year to $8.9 million; the TTM value through Dec 2025 reached $8.9 million, up 2.21%, while the annual FY2025 figure was $8.9 million, 2.21% up from the prior year.
  • Shares Outstanding reached $8.9 million in Q4 2025 per SMTI's latest filing, roughly flat from $8.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $8.9 million in Q4 2025 to a low of $7.6 million in Q2 2021.
  • Average Shares Outstanding over 5 years is $8.4 million, with a median of $8.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: increased 22.78% in 2021, then rose 1.79% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $7.7 million in 2021, then grew by 8.12% to $8.3 million in 2022, then increased by 2.83% to $8.5 million in 2023, then grew by 2.56% to $8.8 million in 2024, then rose by 2.21% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Shares Outstanding are $8.9 million (Q4 2025), $8.9 million (Q3 2025), and $8.9 million (Q2 2025).